BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Expression Profiles of Breast Tumors from Singapore and Europe

Dataset: Expression Profiles of Breast Tumors from Singapore and Europe

To facilitate a better understanding of the molecular heterogeneity of breast cancer and to uncover gene-survival associations that...

Registered by ArrayExpress Uploader
View Dataset

To facilitate a better understanding of the molecular heterogeneity of breast cancer and to uncover gene-survival associations that segregate with distinct molecular subtypes, we recently compiled a meta-analytical database of over 2,000 human breast tumor expression profiles variously annotated for clinical and pathological variables and derived from various institutions worldwide. This database was utilized for the breast tumor study cited below: Nagalla, et. al., Genome Biology, 2013. While the majority of the tumor expression profiles included in this database derived from publicly accessible microarray repositories, a number of the samples had not been previously published. Here, we describe the origin of these samples and provide their associated clinical and pathological annotations with the hope that other investigators will be able to utilize these data in their own research. Breast tumor samples derived from the Institut Jules Bordet (IJB; Belgium), John Radcliffe Hospital (JRH; Oxford) and the National University Hospital (NUH, Singapore) were profiled on the Affymetrix U133A platform. The number of tumors profiled (n) and the corresponding dates of tumor diagnosis are as follows. IJB: n=41, 1994-2001; JRH: n=8, 1990-1993; and NUH: n=100, 2000-2002.

Species:
human

Samples:
139

Source:
E-GEOD-45255

Updated:
Dec.12, 2014

Registered:
Jun.18, 2014


Factors: (via ArrayExpress)
Sample DSS TIME LN STATUS HER2 STATUS DMFS EVENT DEFINED AS DISTANT METASTASIS OR DEATH FROM BREAST CANCER CHARACTERISTICS HISTOLOGICAL GRADE SIZE MM TREATMENT TYPE DFS TIME PATIENT AGE DMFS TIME PGR STATUS YES DSS EVENT DEFINED AS DEATH FROM BREAST CANCER ER STATUS DFS EVENT DEFINED AS ANY TYPE OF RECURRENCE OR DEATH FROM BREAST CANCER HISTOLOGY
GSM1100175 NA LN- NA not specified endocrine? (0=no, 1=yes): 0 G1 21 none 9.42 43 9.419 NA not specified NA ER+ not specified NA
GSM1100174 NA LN- NA not specified endocrine? (0=no, 1=yes): 0 G2 23 none 10.61 37 10.614 NA not specified NA ER- 1 NA
GSM1100173 NA LN- NA 1 endocrine? (0=no, 1=yes): 0 NA 10 none 7.15 67 7.151 NA not specified NA ER- 1 NA
GSM1100172 1.66027397260274 LN- He- not specified endocrine? (0=no, 1=yes): 0 G3 29 CMFx6 NA 50 1.66 PgR- 1 not specified ER- NA NA
GSM110017 4.50958904109589 LN- He- not specified endocrine? (0=no, 1=yes): 1 G2 20 tamoxifen NA 72 4.51 PgR- 1 not specified ER+ NA NA
GSM1100170 3.92602739726027 LN- He+ not specified endocrine? (0=no, 1=yes): 1 G1 30 tamoxifen NA 56 3.93 PgR+ 1 not specified ER+ NA NA
GSM1100169 4.95890410958904 LN- He- not specified endocrine? (0=no, 1=yes): 1 G3 27 CMFx6; Tamoxifen NA 46 4.96 PgR- 1 not specified ER- NA NA
GSM1100168 4.56164383561644 LN- He+ not specified endocrine? (0=no, 1=yes): 1 G2 30 tamoxifen NA 45 4.56 PgR+ 1 not specified ER+ NA NA
GSM1100167 5.00821917808219 LN- He+ not specified endocrine? (0=no, 1=yes): 0 G3 60 CMFx6 NA 48 5.01 PgR- 1 not specified ER- NA NA
GSM1100166 4.64383561643836 LN- He- not specified endocrine? (0=no, 1=yes): 0 G2 20 CMFx6 NA 45 4.64 PgR+ 1 not specified ER+ NA NA
GSM1100165 5.13424657534247 LN- He- not specified endocrine? (0=no, 1=yes): 1 G2 20 tamoxifen NA 70 5.13 PgR- 1 not specified ER+ NA NA
GSM1100164 6.25753424657534 LN- NA not specified endocrine? (0=no, 1=yes): 0 G3 45 ACx4 NA 59 6.26 PgR- 1 not specified ER- NA NA
GSM1100163 5.56712328767123 LN- He- not specified endocrine? (0=no, 1=yes): 1 G3 14 CMFx6; Arimidex/Tamoxifen NA 61 5.57 PgR- 1 not specified ER- NA NA
GSM1100162 5.10958904109589 LN- He- not specified endocrine? (0=no, 1=yes): 1 G3 20 ACx4; Arimidex/Tamoxifen NA 60 5.11 PgR+ 1 not specified ER+ NA NA
GSM110016 5.52328767123288 LN- He- not specified endocrine? (0=no, 1=yes): 1 G3 19 tamoxifen NA 53 5.52 PgR+ 1 not specified ER+ NA NA
GSM1100160 6.69315068493151 LN- He- not specified endocrine? (0=no, 1=yes): 0 G2 14 CMFx6 NA 42 6.69 PgR+ 1 not specified ER+ NA NA
GSM1100159 6.18630136986301 LN- He- not specified endocrine? (0=no, 1=yes): NA NA 38 NA NA 73 6.19 PgR- NA not specified ER- NA NA
GSM1100158 2.57260273972603 LN- NA not specified endocrine? (0=no, 1=yes): 1 G3 32 CMFx6; Tamoxifen NA 46 2.57 NA 1 not specified NA NA NA
GSM1100157 3.11506849315069 LN- He+ not specified endocrine? (0=no, 1=yes): 1 G1 20 tamoxifen NA 57 3.12 PgR- 1 not specified ER+ NA NA
GSM1100156 5.93698630136986 LN- He- not specified endocrine? (0=no, 1=yes): 1 G1 27 tamoxifen NA 66 5.94 PgR+ 1 not specified ER+ NA NA
GSM1100155 6.12876712328767 LN- He+ not specified endocrine? (0=no, 1=yes): 1 G3 27 tamoxifen NA 62 6.13 PgR+ 1 not specified ER+ NA NA
GSM1100154 6.61369863013699 LN- He- not specified endocrine? (0=no, 1=yes): 1 G3 40 ACx6; Tamoxifen NA 67 6.61 PgR- 1 not specified ER- NA NA
GSM1100153 6.65205479452055 LN- He+ not specified endocrine? (0=no, 1=yes): 1 G2 35 tamoxifen NA 70 6.65 PgR- 1 not specified ER+ NA NA
GSM1100152 6.17534246575342 LN- He+ not specified endocrine? (0=no, 1=yes): 1 G2 15 tamoxifen NA 77 6.18 PgR+ 1 not specified ER+ NA NA
GSM110015 6.01917808219178 LN- He+ not specified endocrine? (0=no, 1=yes): 1 G2 20 ACx4; Tamoxifen NA 52 6.02 PgR- 1 not specified ER- NA NA
GSM1100150 7.57260273972603 LN- He+ not specified endocrine? (0=no, 1=yes): 1 G2 20 tamoxifen NA 81 7.57 PgR- 1 not specified ER+ NA NA
GSM1100149 7.30684931506849 LN- He- not specified endocrine? (0=no, 1=yes): 1 G3 18 tamoxifen NA 55 7.31 PgR+ 1 not specified ER+ NA NA
GSM1100148 7.85479452054795 LN- He+ not specified endocrine? (0=no, 1=yes): 1 G2 12 Tamoxifen+Zoledronic acid NA 48 7.85 NA 1 not specified ER+ NA NA
GSM1100147 7.82191780821918 LN- He- not specified endocrine? (0=no, 1=yes): 1 G2 10 tamoxifen NA 54 7.82 PgR- 1 not specified ER- NA NA
GSM1100146 5.16438356164384 LN- He+ 1 endocrine? (0=no, 1=yes): 1 G3 37 Arimidex/Tamoxifen NA 72 3.30 PgR+ 1 not specified ER+ NA NA
GSM1100145 6.75068493150685 LN- He- 1 endocrine? (0=no, 1=yes): 1 G3 40 CMFx2; Tamoxifen NA 60 3.65 PgR+ 1 not specified ER+ NA NA
GSM1100144 8.02191780821918 LN- He- 1 endocrine? (0=no, 1=yes): 0 G1 55 ACx4 NA 54 6.15 PgR- 1 not specified ER+ NA NA
GSM1100143 7.07945205479452 LN- He- 1 endocrine? (0=no, 1=yes): 1 G2 13 Tamoxifen+Zoledronic acid NA 36 2.42 PgR- 1 not specified ER- NA NA
GSM1100142 2.18904109589041 LN- He- not specified endocrine? (0=no, 1=yes): 1 G1 10 Tamoxifen+Zoledronic acid NA 46 2.18 PgR- 1 not specified ER+ NA NA
GSM110014 0.991780821917808 LN- He+ 1 endocrine? (0=no, 1=yes): 1 G3 35 tamoxifen NA 70 0.76 PgR+ 1 1 ER+ NA NA
GSM1100140 4.62191780821918 LN- He- 1 endocrine? (0=no, 1=yes): 0 G3 34 ACx3/CMFx1 NA 73 3.80 PgR- 1 1 ER- NA NA
GSM1100139 4.92876712328767 LN- He- 1 endocrine? (0=no, 1=yes): 1 G3 46 tamoxifen NA 63 2.21 PgR+ 1 1 ER+ NA NA
GSM1100138 2.75342465753425 LN- He- 1 endocrine? (0=no, 1=yes): 1 G3 32 ECx4; Tamoxifen NA 38 1.35 PgR- 1 1 ER+ NA NA
GSM1100137 5.03561643835616 LN- He+ 1 endocrine? (0=no, 1=yes): 1 NA 85 tamoxifen NA 57 0.25 PgR+ 1 1 ER+ NA NA
GSM1100136 6.17260273972603 LN- He- 1 endocrine? (0=no, 1=yes): 1 G3 17 tamoxifen NA 68 4.51 PgR+ 1 1 ER+ NA NA
GSM1100135 4.19452054794521 LN- He- 1 endocrine? (0=no, 1=yes): 1 G3 21 tamoxifen NA 66 4.18 PgR- 1 1 ER- NA NA
GSM1100134 3.07945205479452 LN- He+ 1 endocrine? (0=no, 1=yes): 1 G3 25 tamoxifen NA 59 0.65 PgR- 1 1 ER- NA NA
GSM1100133 2.12602739726027 LN- He+ 1 endocrine? (0=no, 1=yes): 1 G3 28 CMFx6; Tamoxifen NA 47 1.39 PgR+ 1 1 ER+ NA NA
GSM1100132 3.44931506849315 LN- He+ 1 endocrine? (0=no, 1=yes): 1 G2 30 tamoxifen NA 63 3.05 NA 1 1 ER+ NA NA
GSM110013 4.33 LN+ NA not specified endocrine? (0=no, 1=yes): 1 G3 35 Tam+CMFx6 cycles 4.33 53 4.33 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100130 4.83 LN+ He- not specified endocrine? (0=no, 1=yes): NA G1 60 NA 4.83 59 4.83 PgR+ NA not specified ER+ not specified invasive ductal carcinoma
GSM1100129 4.38 LN- He- not specified endocrine? (0=no, 1=yes): 1 G3 20 tamoxifen 4.38 62 4.38 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100128 2.67 LN+ He- not specified endocrine? (0=no, 1=yes): 1 G1 24 Tam+ACx4 cycles 2.67 43 2.67 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100127 4.67 LN- NA not specified endocrine? (0=no, 1=yes): 0 G1 25 none 4.67 55 4.67 NA not specified not specified NA not specified invasive ductal carcinoma and papillary carcinoma
GSM1100126 0.83 LN- He- not specified endocrine? (0=no, 1=yes): 1 G3 28 tamoxifen 0.83 84 0.83 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100125 2.00 LN+ He+ 1 endocrine? (0=no, 1=yes): 1 G3 40 Tam+AC 2.00 38 2.00 PgR+ 1 not specified ER+ 1 invasive ductal carcinoma
GSM1100124 4.92 LN+ He+ not specified endocrine? (0=no, 1=yes): 1 G3 25 tamoxifen 4.92 67 4.92 PgR- 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100123 5.17 LN- He- not specified endocrine? (0=no, 1=yes): 1 G1 20 tamoxifen 5.17 52 5.17 PgR+ 1 not specified ER+ not specified invasive lobular carcinoma
GSM1100122 5.75 LN+ He+ 1 endocrine? (0=no, 1=yes): 1 G3 16 Tam+ACx4 cycles 3.83 50 3.83 PgR+ 1 not specified ER- 1 invasive ductal carcinoma
GSM110012 5.21 LN- He+ not specified endocrine? (0=no, 1=yes): 1 G3 50 tamoxifen 5.21 64 5.21 PgR+ 1 not specified ER+ not specified medullary carcinoma
GSM1100120 4.54 LN+ He- not specified endocrine? (0=no, 1=yes): 0 G3 30 CAF 4.54 47 4.54 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100119 5.58 LN- He+ not specified endocrine? (0=no, 1=yes): 1 G3 38 Tam+ACx4 cycles 5.58 38 5.58 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100118 5.92 LN+ He+ not specified endocrine? (0=no, 1=yes): 1 G3 51 Tam+ACx4 cycles 5.92 58 5.92 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100117 5.88 LN- He+ not specified endocrine? (0=no, 1=yes): 0 G3 21 ACx4 cycles 5.88 47 5.88 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100116 5.79 LN- He- not specified endocrine? (0=no, 1=yes): 1 G3 18 Tam+CMFx6 cycles 5.79 51 5.79 PgR- 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100115 5.83 LN- He+ not specified endocrine? (0=no, 1=yes): 0 G3 35 ACx4 cycles 5.83 48 5.83 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100114 5.83 LN- He- not specified endocrine? (0=no, 1=yes): 0 G3 25 ACx4 cycles 5.83 46 5.83 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100113 5.58 LN- He+ not specified endocrine? (0=no, 1=yes): 0 G3 27 ACx4 cycles 1.92 51 1.33 PgR- 1 not specified ER- 1 invasive ductal carcinoma
GSM1100112 6.17 LN- He- not specified endocrine? (0=no, 1=yes): 1 G3 25 Tam+CMFx6 cycles 6.17 36 6.17 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100 5.83 LN+ He+ not specified endocrine? (0=no, 1=yes): 0 G3 15 CAFx6 cycles 5.83 61 5.83 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100110 5.71 LN- He+ not specified endocrine? (0=no, 1=yes): 0 G3 32 ACx4 cycles 5.71 48 5.71 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100109 5.88 LN+ He- not specified endocrine? (0=no, 1=yes): 0 G3 25 CMF 5.88 61 5.88 PgR- 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100108 6.50 LN- He- not specified endocrine? (0=no, 1=yes): 0 G3 20 none 1.17 42 1.17 PgR- not specified not specified ER- not specified medullary carcinoma
GSM1100107 4.33 LN- He- not specified endocrine? (0=no, 1=yes): 1 G1 40 tamoxifen 3.50 77 3.50 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100106 NA LN- He- NA endocrine? (0=no, 1=yes): 1 G1 40 tamoxifen NA 81 NA PgR+ 1 NA ER+ NA papillary carcinoma
GSM1100105 4.00 LN- He+ not specified endocrine? (0=no, 1=yes): NA G3 23 NA 4.00 42 4.00 PgR- NA not specified ER- not specified invasive ductal carcinoma
GSM1100104 2.88 LN- He+ 1 endocrine? (0=no, 1=yes): 1 G3 36 Tam+ACx4 cycles 2.29 38 2.29 PgR- 1 not specified ER+ 1 invasive ductal carcinoma
GSM1100103 1.46 LN+ He+ 1 endocrine? (0=no, 1=yes): 0 G3 30 ACx4 cycles 0.79 51 0.79 PgR- 1 not specified ER- 1 invasive ductal carcinoma
GSM1100102 5.79 LN- He- not specified endocrine? (0=no, 1=yes): 1 G1 15 Tam+CMFx6 cycles 5.58 60 5.58 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM110010 6.29 LN+ He+ not specified endocrine? (0=no, 1=yes): 1 G3 45 Tam+ACx4 cycles 6.29 52 6.29 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100100 0.75 LN- He- not specified endocrine? (0=no, 1=yes): 0 G3 35 ACx4 cycles 0.75 48 0.75 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100099 4.25 LN- He- not specified endocrine? (0=no, 1=yes): 0 G3 22 AC 4.17 42 4.17 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100098 5.08 LN+ He- not specified endocrine? (0=no, 1=yes): 0 G3 30 ACx4 cycles 5.08 48 5.08 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100097 4.38 LN+ He+ not specified endocrine? (0=no, 1=yes): 0 G3 35 ACx8 cycles; taxol 4.38 34 4.38 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100096 3.04 LN+ He- 1 endocrine? (0=no, 1=yes): 0 G1 80 CAFx6 cycles 2.21 29 2.21 PgR+ 1 1 ER+ 1 invasive lobular carcinoma
GSM1100095 4.38 LN+ He- not specified endocrine? (0=no, 1=yes): 1 G1 21 tamoxifen 3.13 86 3.13 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100094 1.38 LN+ He+ 1 endocrine? (0=no, 1=yes): 0 G3 35 CAF 1.29 54 1.29 PgR- 1 1 ER- 1 invasive ductal carcinoma
GSM1100093 0.38 LN+ He+ 1 endocrine? (0=no, 1=yes): NA G3 22 NA 0.13 46 0.13 PgR- NA 1 ER- 1 invasive ductal carcinoma
GSM1100092 5.54 LN- He- not specified endocrine? (0=no, 1=yes): 0 G3 40 ACx4 cycles 5.54 41 5.54 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM110009 1.96 LN+ He- 1 endocrine? (0=no, 1=yes): 1 G3 40 tamoxifen 1.96 80 1.96 PgR+ 1 not specified ER+ 1 invasive ductal carcinoma
GSM1100090 4.83 LN+ He+ not specified endocrine? (0=no, 1=yes): 0 G3 20 CAF 4.83 45 4.83 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100089 5.08 LN- He+ not specified endocrine? (0=no, 1=yes): 0 G3 30 ACx4 cycles 5.08 64 5.08 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100088 1.00 LN+ He+ 1 endocrine? (0=no, 1=yes): 0 G3 35 none 0.88 62 0.88 PgR- not specified not specified ER- 1 invasive ductal carcinoma
GSM1100087 2.08 LN+ He+ 1 endocrine? (0=no, 1=yes): 1 G3 25 Arimidex+CMFx2 cycles 0.00 62 0.00 PgR+ 1 1 ER+ 1 invasive ductal carcinoma
GSM1100086 1.96 LN+ He+ not specified endocrine? (0=no, 1=yes): 0 G3 30 CAF 1.96 58 1.96 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100085 5.29 LN+ He+ not specified endocrine? (0=no, 1=yes): 0 G3 25 AC 5.25 45 5.25 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100084 4.63 LN+ He+ 1 endocrine? (0=no, 1=yes): 0 G3 20 ACx4 cycles 3.96 54 3.96 PgR- 1 1 ER- 1 invasive ductal carcinoma
GSM1100083 4.00 LN+ NA not specified endocrine? (0=no, 1=yes): 0 G3 50 ACx4 cycles 4.00 44 4.00 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100082 2.25 LN+ He+ 1 endocrine? (0=no, 1=yes): 1 G3 30 tamoxifen 2.04 74 2.04 PgR- 1 1 ER+ 1 invasive ductal carcinoma
GSM110008 4.33 LN+ He+ not specified endocrine? (0=no, 1=yes): 0 G3 35 ACx4 cycles 4.00 52 4.00 PgR- 1 not specified ER- not specified invasive lobular carcinoma
GSM1100080 5.00 LN- He+ not specified endocrine? (0=no, 1=yes): 0 G3 60 ACx4 cycles 1.00 55 1.00 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100079 0.13 LN- He- not specified endocrine? (0=no, 1=yes): 1 G1 38 tamoxifen NA 66 0.13 PgR+ 1 not specified ER+ not specified mucinous carcinoma
GSM1100078 4.88 LN+ He- not specified endocrine? (0=no, 1=yes): 0 G3 32 CAF 4.88 47 4.88 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100077 4.46 LN- He+ not specified endocrine? (0=no, 1=yes): 1 G3 20 tamoxifen 4.46 55 4.46 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100076 5.46 LN- He- not specified endocrine? (0=no, 1=yes): 1 G1 15 tamoxifen;goserelin 5.46 45 5.46 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100075 5.46 LN- He+ not specified endocrine? (0=no, 1=yes): 0 G3 40 ACx4 cycles 1.54 34 1.54 PgR- 1 not specified ER- not specified invasive ductal carcinoma
GSM1100074 5.00 LN- He- not specified endocrine? (0=no, 1=yes): 0 G2 35 ACx4 cycles 5.00 47 5.00 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100073 5.33 LN- He- not specified endocrine? (0=no, 1=yes): 1 G2 15 tamoxifen 5.33 49 5.33 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100072 5.58 LN- He- not specified endocrine? (0=no, 1=yes): 1 G2 12 tamoxifen 5.58 64 5.58 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM110007 0.08 LN- He+ NA endocrine? (0=no, 1=yes): NA G2 17 NA NA 66 NA PgR+ NA not specified ER+ NA invasive ductal carcinoma
GSM1100070 4.50 LN+ He- not specified endocrine? (0=no, 1=yes): NA G2 40 NA 4.00 46 4.00 PgR+ NA not specified ER- not specified invasive ductal and lobular carcinoma
GSM1100069 4.92 LN+ He- not specified endocrine? (0=no, 1=yes): 1 G2 20 tamoxifen 4.83 73 4.83 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100068 4.88 LN- He- not specified endocrine? (0=no, 1=yes): 1 G2 15 Tam+CMFx6 cycles 4.88 46 4.88 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100067 4.50 LN+ He- not specified endocrine? (0=no, 1=yes): NA G2 30 NA 4.50 42 4.50 PgR- NA not specified ER+ not specified invasive ductal carcinoma
GSM1100066 1.75 LN+ He+ 1 endocrine? (0=no, 1=yes): 1 G2 60 Tam+CAFx2 cycles 1.67 46 1.67 PgR- 1 1 ER+ 1 invasive ductal carcinoma
GSM1100065 0.42 LN+ He+ not specified endocrine? (0=no, 1=yes): 0 G2 24 none 0.42 44 0.42 PgR+ not specified not specified ER+ not specified invasive ductal carcinoma
GSM1100064 4.92 LN+ He- not specified endocrine? (0=no, 1=yes): 1 G2 19 tamoxifen 4.92 55 4.92 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100063 4.75 LN- He+ not specified endocrine? (0=no, 1=yes): 1 G2 21 tamoxifen 4.75 57 4.75 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100062 5.17 LN+ He- not specified endocrine? (0=no, 1=yes): 0 G2 23 CAF 5.17 40 5.17 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM110006 4.67 LN- He- not specified endocrine? (0=no, 1=yes): 0 G2 35 CMF 4.67 44 4.67 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100060 5.67 LN+ He+ not specified endocrine? (0=no, 1=yes): 0 G2 30 CAF 5.67 46 5.67 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100059 4.67 LN- He- not specified endocrine? (0=no, 1=yes): 1 G2 40 Tam+ACx4 cycles 4.67 35 4.67 PgR+ 1 not specified ER- not specified invasive ductal carcinoma
GSM1100058 4.58 LN- He- not specified endocrine? (0=no, 1=yes): 0 G2 15 none 1.25 55 0.67 PgR+ not specified not specified ER+ 1 invasive ductal carcinoma
GSM1100057 2.83 LN- He+ 1 endocrine? (0=no, 1=yes): 0 G2 25 none 2.83 67 2.83 PgR- not specified not specified ER- 1 invasive ductal carcinoma
GSM1100056 5.42 LN+ He+ not specified endocrine? (0=no, 1=yes): 1 G2 40 tamoxifen 0.92 75 0.67 PgR+ 1 not specified ER- 1 invasive ductal carcinoma
GSM1100055 3.08 LN- He- 1 endocrine? (0=no, 1=yes): 0 G2 15 anastrozole;taxol 0.04 48 0.04 PgR- 1 1 ER+ 1 invasive lobular carcinoma
GSM1100054 5.25 LN+ He+ not specified endocrine? (0=no, 1=yes): 1 G2 23 Tam+CAFx6 cycles 5.25 49 5.25 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100053 5.00 LN+ He- not specified endocrine? (0=no, 1=yes): 0 G2 25 CAF 5.00 69 5.00 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100052 NA LN+ He+ NA endocrine? (0=no, 1=yes): 1 G2 25 Tam+ACx8;taxol NA 51 NA PgR- 1 NA ER+ NA invasive ductal carcinoma
GSM110005 6.33 LN- He- not specified endocrine? (0=no, 1=yes): 1 G2 20 Tam+CMFx6 cycles 6.33 60 6.33 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100050 5.58 LN- He+ not specified endocrine? (0=no, 1=yes): 1 G2 35 tamoxifen 5.58 77 5.58 PgR- 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100049 5.92 LN+ He- not specified endocrine? (0=no, 1=yes): 0 G2 22 CMF 5.75 53 5.75 PgR+ 1 not specified ER- not specified invasive ductal carcinoma
GSM1100048 5.83 LN+ He- not specified endocrine? (0=no, 1=yes): 0 G2 25 CAF 5.83 50 5.83 PgR+ 1 not specified ER- not specified invasive ductal carcinoma
GSM1100047 5.79 LN- He- not specified endocrine? (0=no, 1=yes): 0 G2 18 CMF 5.79 52 5.79 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100046 6.00 LN- He- not specified endocrine? (0=no, 1=yes): 1 G2 18 tamoxifen 6.00 53 6.00 PgR- 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100045 4.08 LN- He+ not specified endocrine? (0=no, 1=yes): 0 G2 15 none 4.04 46 4.04 PgR- not specified not specified ER- not specified invasive ductal carcinoma
GSM1100044 5.63 LN- He+ not specified endocrine? (0=no, 1=yes): NA G2 20 NA 5.63 48 5.63 PgR+ NA not specified ER+ not specified invasive ductal carcinoma
GSM1100043 2.25 LN+ He+ 1 endocrine? (0=no, 1=yes): 0 G2 60 ACx4 cycles 2.00 54 2.00 PgR- 1 not specified ER- 1 invasive ductal carcinoma
GSM1100042 6.25 LN- He+ not specified endocrine? (0=no, 1=yes): 1 G2 25 tamoxifen 6.25 69 6.25 PgR- 1 not specified ER+ not specified invasive ductal carcinoma
GSM110004 2.63 LN- He+ not specified endocrine? (0=no, 1=yes): 1 G2 25 Tam+CMFx6 cycles 2.63 40 2.63 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100040 6.04 LN- He- not specified endocrine? (0=no, 1=yes): 1 G2 35 tamoxifen 5.88 69 5.88 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100039 4.29 LN- He- not specified endocrine? (0=no, 1=yes): 1 G2 30 tamoxifen 4.29 69 4.29 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100038 1.13 LN+ He+ 1 endocrine? (0=no, 1=yes): 0 G2 30 ACx4 cycles 1.13 62 1.13 PgR- 1 not specified ER- 1 invasive ductal carcinoma
GSM1100037 6.17 LN- He- not specified endocrine? (0=no, 1=yes): 1 G2 20 Tam+ACx4 cycles 6.17 41 6.17 PgR+ 1 not specified ER+ not specified invasive ductal carcinoma

Tags

  • breast
  • breast cancer
  • cancer
  • genome

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2026 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use